Veracyte Gross Margin 2012-2025 | VCYT
Current and historical gross margin for Veracyte (VCYT) over the last 10 years. The current gross profit margin for Veracyte as of March 31, 2025 is %.
| Veracyte Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2025-03-31 | $0.46B | $0.32B | 68.25% |
| 2024-12-31 | $0.45B | $0.30B | 66.82% |
| 2024-09-30 | $0.43B | $0.28B | 65.18% |
| 2024-06-30 | $0.40B | $0.26B | 64.16% |
| 2024-03-31 | $0.38B | $0.24B | 62.93% |
| 2023-12-31 | $0.36B | $0.23B | 63.89% |
| 2023-09-30 | $0.34B | $0.21B | 61.11% |
| 2023-06-30 | $0.33B | $0.20B | 61.28% |
| 2023-03-31 | $0.31B | $0.19B | 60.45% |
| 2022-12-31 | $0.30B | $0.18B | 59.26% |
| 2022-09-30 | $0.28B | $0.19B | 65.49% |
| 2022-06-30 | $0.27B | $0.18B | 65.30% |
| 2022-03-31 | $0.25B | $0.17B | 66.00% |
| 2021-12-31 | $0.22B | $0.15B | 66.21% |
| 2021-09-30 | $0.19B | $0.12B | 66.31% |
| 2021-06-30 | $0.16B | $0.11B | 67.09% |
| 2021-03-31 | $0.12B | $0.08B | 65.32% |
| 2020-12-31 | $0.12B | $0.08B | 64.41% |
| 2020-09-30 | $0.11B | $0.07B | 64.60% |
| 2020-06-30 | $0.11B | $0.07B | 65.49% |
| 2020-03-31 | $0.12B | $0.08B | 67.21% |
| 2019-12-31 | $0.12B | $0.08B | 69.42% |
| 2019-09-30 | $0.12B | $0.08B | 69.23% |
| 2019-06-30 | $0.11B | $0.07B | 67.89% |
| 2019-03-31 | $0.10B | $0.07B | 66.67% |
| 2018-12-31 | $0.09B | $0.06B | 64.13% |
| 2018-09-30 | $0.09B | $0.05B | 62.79% |
| 2018-06-30 | $0.08B | $0.05B | 60.49% |
| 2018-03-31 | $0.08B | $0.05B | 59.21% |
| 2017-12-31 | $0.07B | $0.04B | 59.72% |
| 2017-09-30 | $0.07B | $0.04B | 61.43% |
| 2017-06-30 | $0.07B | $0.05B | 63.38% |
| 2017-03-31 | $0.07B | $0.04B | 61.76% |
| 2016-12-31 | $0.07B | $0.04B | 59.09% |
| 2016-09-30 | $0.06B | $0.04B | 56.45% |
| 2016-06-30 | $0.06B | $0.03B | 54.55% |
| 2016-03-31 | $0.05B | $0.03B | 55.77% |
| 2015-12-31 | $0.05B | $0.03B | 59.18% |
| 2015-09-30 | $0.05B | $0.03B | 59.57% |
| 2015-06-30 | $0.05B | $0.03B | 60.00% |
| 2015-03-31 | $0.04B | $0.03B | 59.52% |
| 2014-12-31 | $0.04B | $0.02B | 57.89% |
| 2014-09-30 | $0.03B | $0.02B | 54.55% |
| 2014-06-30 | $0.03B | $0.01B | 48.28% |
| 2014-03-31 | $0.03B | $0.01B | 44.00% |
| 2013-12-31 | $0.02B | $0.01B | 40.91% |
| 2013-06-30 | $0.01B | $0.01B | 41.67% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $2.113B | $0.446B |
| Veracyte, Inc. is a diagnostics company. It is focused on discovering, developing and commercializing molecular cytology solutions. The Company provides Afirma Thyroid FNA Analysis, which helps physicians in reducing unnecessary diagnostic surgeries for patients with thyroid nodules. Veracyte is also developing Afirma Malignant GEC test. It serves endocrinologists, radiologists, and head and neck specialists. Veracyte, Inc. is headquartered in South San Francisco, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $200.019B | 87.61 |
| Thermo Fisher Scientific (TMO) | United States | $150.378B | 18.19 |
| Edwards Lifesciences (EW) | United States | $45.620B | 29.91 |
| Alcon (ALC) | Switzerland | $42.878B | 28.98 |
| IDEXX Laboratories (IDXX) | United States | $41.997B | 48.26 |
| DexCom (DXCM) | United States | $33.619B | 51.96 |
| IQVIA Holdings (IQV) | United States | $25.495B | 14.28 |
| Mettler-Toledo (MTD) | United States | $24.204B | 28.78 |
| STERIS (STE) | Ireland | $23.962B | 26.39 |
| Waters (WAT) | United States | $20.610B | 29.08 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.452B | 0.00 |
| Hologic (HOLX) | United States | $14.055B | 15.27 |
| Sysmex ADR (SSMXY) | Japan | $10.248B | 29.07 |
| Penumbra (PEN) | United States | $10.006B | 78.54 |
| Masimo (MASI) | United States | $8.931B | 32.94 |
| Globus Medical (GMED) | United States | $8.062B | 19.21 |
| Teleflex (TFX) | United States | $5.411B | 8.93 |
| Glaukos (GKOS) | United States | $5.296B | 0.00 |
| TransMedics (TMDX) | United States | $4.586B | 99.70 |
| Integer Holdings (ITGR) | United States | $4.218B | 22.10 |
| PROCEPT BioRobotics (PRCT) | United States | $3.599B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.445B | 14.56 |
| Nihon Kohden (NHNKY) | Japan | $2.253B | 25.84 |
| Elekta AB (EKTAY) | Sweden | $1.973B | 17.74 |
| Alphatec Holdings (ATEC) | United States | $1.818B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.376B | 0.00 |
| Artivion (AORT) | United States | $1.244B | 116.48 |
| Pulse Biosciences (PLSE) | United States | $1.098B | 0.00 |
| OPKO Health (OPK) | United States | $1.086B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.033B | 5.49 |
| Beta Bionics (BBNX) | United States | $0.848B | 0.00 |
| SiBone (SIBN) | United States | $0.812B | 0.00 |
| IRadimed (IRMD) | United States | $0.767B | 38.94 |
| RxSight (RXST) | United States | $0.606B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.588B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.570B | 8.87 |
| Mesa Laboratories (MLAB) | United States | $0.544B | 12.76 |
| OrthoPediatrics (KIDS) | United States | $0.507B | 0.00 |
| AxoGen (AXGN) | United States | $0.492B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.445B | 0.00 |
| NeuroPace (NPCE) | United States | $0.436B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.420B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.364B | 9.69 |
| Treace Medical Concepts (TMCI) | United States | $0.363B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.359B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.300B | 0.00 |
| Neuronetics (STIM) | United States | $0.252B | 0.00 |
| 908 Devices (MASS) | United States | $0.240B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.235B | 14.24 |
| Sight Sciences (SGHT) | United States | $0.217B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.198B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.179B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.171B | 0.00 |
| Inogen (INGN) | United States | $0.169B | 0.00 |
| CVRx (CVRX) | United States | $0.168B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.157B | 0.00 |
| Accuray (ARAY) | United States | $0.157B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.155B | 0.00 |
| LENSAR (LNSR) | United States | $0.154B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.131B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.111B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.097B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.090B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.083B | 50.30 |
| InspireMD (NSPR) | United States | $0.077B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.068B | 0.00 |
| Hyperfine (HYPR) | United States | $0.067B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.061B | 0.00 |
| Positron (POSC) | United States | $0.052B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.045B | 0.00 |
| Spectral AI (MDAI) | United States | $0.045B | 0.00 |
| Precision Optics (POCI) | United States | $0.034B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Envoy Medical (COCH) | United States | $0.030B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.028B | 0.00 | |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.017B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.010B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.009B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.37 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |